InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Ren Ken. Insider active across 1 company, notably CASI Pharmaceuticals, Inc.. Cumulatively, 4 disclosures have been logged. Split: 4 buys · 0 sell. Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Ren Ken is a declarant linked to CASI Pharmaceuticals, Inc., where he is listed as CEO and Director. The record shows 4 filings in total, all within the sampled filings dated 2016-01-21, with the transaction nature indicated as Acquisition and aggregate buy and sell amounts of EUR 0.